Alvimedica

Alvimedica, a Turkish medical device company, will open a new stent production facility in Turkey in March 2019. The plant will produce 900,000 stents per year at full capacity, create 1,000 jobs, and help the company expand into the Middle East market.

Alvimedica is ready to launch its mega stent production facility in Istanbul with an investment of 1.7 billion Turkish liras ($310 million), set to produce 900,000 stents annually.

Alvimedica will invest $30 million to build a new factory in Çatalca, Turkey, for the production of interventional cardiology devices. The plant is planned to begin service in autumn 2018.

Turkish interventional cardiology firm Alvimedica plans to invest around $370 million to build a new manufacturing plant in Turkey, its third, to meet demand for its Cre8 drug-eluting stents and balloons. The investment will be supported by Turkish government incentives.

Alvimedica, a Turkish medical device company, announced plans to start manufacturing stents in Turkey in 2018 to reduce import dependency, with the goal of exporting high-quality stents.

Alvimedica held a groundbreaking ceremony for its third factory in Çatalca, Istanbul. The new facility will cover 7,500 square meters of production area and increase capacity for drug-eluting stents and balloons.